In our study, we first demonstrated through RNA-seq analysis that PBX3 can activate the EMT pathway in HCC cells and then found that PBX3 was significantly upregulated in HCC specimens and exerted an oncogenic biological effect in HCC cells. The gene discussed is PBX3; the disease is hepatocellular carcinoma.